not logged in Login

European Urology

Supplements

European Urology Supplements

Volume 4, issue 2, pages 1-70, February 2005 | UPDATE SERIES

Viewing articles 1-10 of 10

Editorial Board

page i

Full-Text PDF (29 KB)

The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)

Claude C. Schulman, Ragnar Asplund, François Desgrandchamps and Udo Jonas

pages 1 - 8

Abstract Full Text Full-Text PDF (254 KB)

Create Platinum Slide Series

Cardiovascular Safety of Tamsulosin Modified Release in the Fasted and Fed State in Elderly Healthy Subjects

Martin C. Michel, Cees Korstanje and Walter Krauwinkel

pages 9 - 14

Abstract Full Text Full-Text PDF (302 KB)

Create Platinum Slide Series

The Pharmacokinetic Profile of Tamsulosin Oral Controlled Absorption System (OCAS^®)

Martin C. Michel, Cees Korstanje, Walter Krauwinkel and Mirjam Kuipers

pages 15 - 24

Abstract Full Text Full-Text PDF (303 KB)

Create Platinum Slide Series

Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): Efficacy and Tolerability in a Phase 2b Dose-Response Study

Christopher R. Chapple, Jerzy Lorenz, Raymond Mortensen, Harald Pauthner, Mario O. Reis, Claude C. Schulman and Ingrid van der Putten-Slob

pages 25 - 32

Abstract Full Text Full-Text PDF (223 KB)

Create Platinum Slide Series

Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): Efficacy and Tolerability in a Placebo and Active Comparator Controlled Phase 3a Study

Christopher R. Chapple, Salman H. Al-Shukri, Bernard Gattegno, Simon Holmes, José M. Martínez-Sagarra, Roberto M. Scarpa, Oncko B. van Vierssen Trip, Viktor Vik and Ingrid van der Putten-Slob

pages 33 - 44

Abstract Full Text Full-Text PDF (312 KB)

Create Platinum Slide Series

Comparison of Vascular α₁-Adrenoceptor Antagonism of Tamsulosin in Oral Controlled Absorption System (OCAS) and Modified Release (MR) Formulations

Martin C. Michel, Cees Korstanje, Walter Krauwinkel, Michael Shear, Jonathan Davies and Adrian Quartel

pages 45 - 52

Abstract Full Text Full-Text PDF (305 KB)

Create Platinum Slide Series

Cardiovascular Safety of the Oral Controlled Absorption System (OCAS) Formulation of Tamsulosin Compared to the Modified Release (MR) Formulation

Martin C. Michel, Cees Korstanje, Walter Krauwinkel, Michael Shear, Jonathan Davies and Adrian Quartel

pages 53 - 60

Abstract Full Text Full-Text PDF (206 KB)

Create Platinum Slide Series

The Impact of Tamsulosin Oral Controlled Absorption System (OCAS) on Nocturia and the Quality of Sleep: Preliminary Results of a Pilot Study

Bob Djavan, Shirin Milani, Jonathan Davies and John Bolodeoku

pages 61 - 68

Abstract Full Text Full-Text PDF (270 KB)

Create Platinum Slide Series

Subject Index

page 69

Full-Text PDF (26 KB)

Viewing articles 1-10 of 10

Search

Listing options

More about Update Series

European Urology

Supplements

European Urology Supplements

Editorial Board

The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)

Cardiovascular Safety of Tamsulosin Modified Release in the Fasted and Fed State in Elderly Healthy Subjects

The Pharmacokinetic Profile of Tamsulosin Oral Controlled Absorption System (OCAS^®)

Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): Efficacy and Tolerability in a Phase 2b Dose-Response Study

Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): Efficacy and Tolerability in a Placebo and Active Comparator Controlled Phase 3a Study

Comparison of Vascular α₁-Adrenoceptor Antagonism of Tamsulosin in Oral Controlled Absorption System (OCAS) and Modified Release (MR) Formulations

Cardiovascular Safety of the Oral Controlled Absorption System (OCAS) Formulation of Tamsulosin Compared to the Modified Release (MR) Formulation

The Impact of Tamsulosin Oral Controlled Absorption System (OCAS) on Nocturia and the Quality of Sleep: Preliminary Results of a Pilot Study

Subject Index

Search

Listing options

Instructions for authors

Top 10 cited